Atlas Trials

A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT04419506 · COMPLETED

Trial details

NCT number
NCT04419506
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis
Start date
2020-07-28
Primary completion
2021-10-06
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.